7
Feb
2019

Meet the Kilimanjaro Climb to Fight Cancer Team

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

A Trek in the Himalayas for Cancer Research
Three Lessons for Business Ahead of JPM, from the Kilimanjaro Climb to Fight Cancer
Join Me and a Biotech Team on the Trek of a Lifetime for Cancer Research
An Unforgettable Experience: The Kilimanjaro Climb to Fight Cancer Yearbook